Sanara Medtech Inc. · NASDAQ:SMTI
Sanara Medtech — Investor Presentation (February 2021)
38 slides from Sanara Medtech's investor presentation, Feb 23, 2021
Slide 1: Sanara MedTech Overview
Sanara MedTech Overview (Nasdaq: SMTI) February 2021 Sanara MedTech
Slide 2: Disclaimers
i Sonora Disclaimers aumtae wmupae nation mee ‘Sey te wher aco hat eran maton twee, roheneecgtontegosy appease secueiaes nnn mn aNB AYO. ‘reste pou suse ane np a nara Sean pase eh el Toxfoimans osc manana wen app owen ee pom aur tisfevetason concen cram posits a arate nventgson aa ih nave not yatta
Slide 3: Company Overview
Company Overview Sanara MedTech
Slide 4: About Sanara MedTech
About Sanara MedTech tha foous an mpcoing patent oucomastwugh evience-bated heating tectnobgies, Sanaa MedTech In. markets ad dtibutes advanced sural ese repair and wound ere produc in the Unied Stale. + Wighty competitive propriety product potoio mn CotertaRX Surin Actvated Colagen = GIAKOS Anticob
Slide 5: Sanara's Six Wound Care and Surgical Site Therapy Focus Areas
Sanara’s Six Wound Care and Surgical Site Therapy Focus Areas Sanara’s strategy is to create a value proposition through the use of efficacious products and services in the appropriate care settings for wound & skin care trey Kanaan carry wat ha Rah Btn Sete St WANDS. cone ols HYCOL an Care & powcr
Slide 6: Opportunity Overview
Opportunity Overview ‘We believe the Surgical and Chronic Wound and Skin Care industry is Poised for Disruption therein How big isthe opportunity? laces alow veal cit fare > $2860 3.5 - $10 Billion! ‘ny dove the surgical and ehonle wound and shin cae Indu need tbe ‘tarts? gree oct fr pat tiny mv ugh
Slide 7: canara
canara iad (3) SERESz @evranner uc les vo hehehe earn F tema reneone Oy >EamithSnephow HEALTHRONT meager & ae @csraursr Lie x Healogics Shochal Tans Weararvsr ROMS B aa PIPER|SANOLER Healogios exsmonr 3° ANNE se
Slide 8: Comprehensive Wound and Skin Care Strategy
Comprehensive Wound and Skin Care Strategy
Slide 9: Surgical Wound Disruptive Strategies
© Sulgaal Wounse ave te argest escare se cund caretoning $1978 (Gettong con of eecoonay © 15.30 suger in tn US. encn yo {eyedeg oir suger, FAM IBASC ad Surgical Wound Disruptive Strategies Recuce he gconomeandeinea!ursenot mnt actrocistes parted anruaty athe US" Mo anctnee paceman) — 270k 9s and 680
Slide 10: Wound Care Disruptive Strategies
Wound Care Disruptive Strategies nt Wound Problem ©) FeesForSenearenburerent system santas — Emphasis on obtaining payment coves to maximize io aged wih vate propotion — Etteacy and outcomes nat aigned wi ebursement © Core sings area eps: — Hospital 3-5 days) — LTAC 28 cays) 1 No continuum o cae ner
Slide 11: Comprehensive Wound & Skin Solution for All Settings
Comprehensive Wound & Skin Solution for All Settings ‘Sanara plans to delver a comprehensive wound care ecosystem targeting the entre continuum of care, with services expected to arve further product sales and shareholder value All Care Settings Physician Inpatient, Physician Cinics and Home nygidan
Slide 12: SMTI Surgical Division
SMTI Surgical Division
Slide 13: Surgical Division — Overview
a} & canara Surgical Division — Overview + The surgical division markets and distributes ColrateRX Surgical primanly to hospitals and ambulatory surgical centers /ASCs") for use by surgeons in their facies, + eollerateRX Surscalis sold through a growing network of independent surgical specialty sale
Slide 14: Surgical Division — Products
Surgical Div CellerateRX Surgical ion — Products + CellerateRX Surgical Activated Collagen Powder is composed of medical hydrolysate of Type | bovine collagen that is approximately 4/00tn the size of native collagen + CellerateRX Surgical is hydrolyzed collagen that ads in the management of surgical
Slide 15: + Excatedin December 2020
+ Excatedin December 2020 + Stain apart Se in, ete nt te sre ge COOK FORTIFY FLOWABLE™ Exaceliar Matic nt Ammon Matt BIOTECH em = nega ost Feeney RLOMaLE emcee SSeansconng weet
Slide 16: Surgical Market Overview and Regional Sales Managers
Surgical Market Overview 17 Surgical Regional Sales Managers (‘RSMs") 80 active 1099 Agent groups with the ability to market CellerateRX Surgical —We estimate that approximately 200 reps are selling CellerateRX Surgical today In 2020, approximately 75% of Sanara’s CellerateRX Surgical applications w
Slide 17: SMTI Wound Care Division
SMTI Wound Care Division Sanara MedTech
Slide 18: Wound Care Division — Overview
Wound Care Division — Overview + The chronic wound division markets and distributes the following products: BIAKOS Antimicrobial Skin and Wound Cleanser, BIAKOS Antimicrobial Wound Gel, BIAKOS Antimicrobial Skin and Wound Irrigation Solution and HYCOL powder and gel. + The chronic wound division pri
Slide 19: Wound Care Division — Products
Wound Care Division — Product: congas ype rtm ayassgente See Neeeaa mecipateecees | onemmeanens mm aan eter 1 pranse nee ‘pe seona rasa + ign ag apr ae ne tte axe :
Slide 20: BIAKOS Antimicrobial Skin and Wound Gel
BIAKOS Antimicrobial Skin and Wound Gel was launched in November 2020 to complement BIAKOS Antimicrobial ‘Skin and Wound Cleanser. The ge! can be applied and will remain in wounds for up to 72 hours, helping to continue disrupting biofilm microbes + la suty conducted n 2070, BUAKOS Ansmiroial Wound
Slide 21: Wound Care Salesforce Overview
Wound Care Salesforce Overview © 5 Wound Care RSMs cover 31 States with each managing their Region 2 Products are sold by RSMs and supplemented by major medical-surgical distributors, independent distributors and currently 9 DME distributors RSMs educate, support and train 45 independent post-acute
Slide 22: Diagnostic Technologies and Virtual Consult Services
Diagnostic Technologies and Virtual Consult Services
Slide 23: Diagnostic and Technology Partnerships
's Diagnostic and Technology Partnerships Diagnostic and technology partnerships expected to drive patient aggregation into the Sanara ecosystem starting in 2021 Investments and Partnerships + Gar solaborson platoon sows tr irope technology in carn markets ‘cate of evonie wounds and skin nthe home B
Slide 24: Precision Healing — Investment and Exclusive Use of Technology
Precision Healing — Investment and Exclus of Technology Company Overview ‘Retail Opportunity Diagnostic Capabiities + Nov and apts apron a 7 ‘mubibon-dolar unmet need in the are of shin sod ebvone wounds ‘Amount andlecaton ot + Fits nae for diagnostic and decison ‘support across Un continuum of care
Slide 25: i} Sanara
i} Sanara Precision | Tissue Healing analytes NADH Cea Activity “Tasue Onmety (0, ge) v v v v v v v BED 10% accra are dsc AD} + tage
Slide 26: Wound and Skin Virtual Consult Services
i} Sanara Wound and Skin Virtual Consult Services Care Provided ‘fated providers ofer + Abily to provide prompt, costetfectve and scalable vital tae Wa tlemedeine + 48:nour diagnosis (5. up to sk months to get an in-person “ppointment in same cases) + Abity to tiage consumer, recommend and prescribe
Slide 27: Product Pipeline
Product Pipeline Sanara MedTech
Slide 28: Product Pipeline (1/2)
Product Pipeline (4/2) ‘BAKE OTC Han and hn Cans + Testing ows mat BAKO ieee aga on 0a tpn hanahpiene proces ‘etonenle one go el elder omned mrs aes, Seances hnguin ns ‘Sedeuing pen tresses fcc otinsecten (ncn sone sing hn set + Leanses rom Reel indus, + Plans te commersaien 2021 + Uoenae rom Roonaa
Slide 29: Product Pipeline (2/2)
Date Product Pipeline (2/2) + Coteratah Surgical a ‘moses yee of Type | ‘ovine cokagen nated ar Shemanoperant ot surge oumate and po ott. lira and second degre barns + Leenses rm Applied +200 1+ Second gonrason HYCOL, Encemencies oneerner etree + Usenses tom Aopies +2023 + Organ steal for a wound (2
Slide 30: Investment Highlights
Investment Highlights Proven executive leadership team vith a long-term track record of value creation
Slide 31: Surgical Care Case Studies
Surgical Care Case Studies Sanara MedTech
Slide 32: Case Overview
Case Overview Beyond male wan acu veumate lower exvemty my sustaned an open Wace of he Ua ae fla om a moloreycle acoder, WOT evence of Segment bones + Init vestments a ona utr, platen of Caleta X Sura! Powder and ns ‘alacant mans ffs stars str nan mating ot Su 8B + Sustanedheaiog was evident at six
Slide 33: Hip Replacement with Comorbidities
Hip Replacement with Comorbidities Case Overview Msieagod omaio wih a story of diabetes, obey, rowous hp replacement wih compleatans tha layed wound heaing, and prev sual ste * ae Sd er sugery fr br aati ip epiacomant Mp rplocement mos pertormed asd lst was ask Bor not fe neaton sae, MON + CoterateR
Slide 34: Open Distal Femur Fracture
Open Distal Femur Fracture Case Overview Coys emus wit airy of >24hour Gey srgery ae to oer mace compeeatons, revo 1 ke rolacemart ate + Paterthod on open asta emu acre afer a mole vniciaccdent that was corpcted wih a contaminated wound st. Surgery was delayed 0 adress oer, ror pee hea sss whe nrase
Slide 35: Wound Care Case Studies
Wound Care Case Studies Sanara MedTech
Slide 36: Case Overview
© Sanara Case Overview TQS # ed rare fc wea sory of creel acon, hotepsPypetensen,hyperipera nay Val econ, Tena eMeoHSM Te patna tae acon sndyd ol cae ung mist wound eng princes bt ns showing no pres ne ws sched fra lst gety ‘The wound wa cleansed wit neal sane. HYCOL Hyajzed Cotagen powder was apple
Slide 37: Diabetic Ulcer
Diabetic Ulcer Case Overview 46 yo Hepaniemne wa prerariedto aUPor 3 woeks pox ndon and ranage Incuang igh Sh Gol amputale ona para ray resacon CalerataRX Ga was apie every 23 days. was covered with appropratecressing to maitan molt wound healing Woundsise 10omx8om x05 || Wound ize” 02am 0 22m
Slide 38: Spina Bifida Pressure Ulcer Case
* SeveinsSa Ware Care Bie Freoenent Rigorans Baring SOVIETS Bondemic Washe-e5x350250 | won Palen Histon: + 6yo white female bom wi Spina Bia +1985 ~ stage 4 PU wi osteomyelitis requing bone excision and ap osure + 19agand2019-Recamences cf stage 4 PU wih esteonyets easing bone + 2019-4 recurance and
Sanara MedTech — Investor Presentation (February 2021) on 6ix